Michelle M. Adams
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michelle M. Adams has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- Ayca Arslan-Ergul
Bilkent University National Nanotechnology Research Center (UNAM), Ankara, Türkiye
5 shared publications Ayca Arslan-Ergul
3 shared publications- Begun Erbaba
Department of Evolutionary Neuroscience The George Washington University Washington D.C. USA
3 shared publications - Elif Tugce Karoglu
Bilkent Universitesi, 52948, Neuroscience, Ankara, Turkey;
3 shared publications Begun Erbaba
Interdisciplinary Program in Neuroscience, Aysel Sabuncu Brain Research Center, Bilkent University, Ankara, Turkey; National Nanotechnology Research Center (UNAM), Bilkent University, Ankara, Turkey; Department of Molecular Biology and Genetics, Zebrafish Facility, Bilkent University, Ankara, Turkey
2 shared publications- Dilan Celebi-Birand
Bilkent Universitesi, 52948, Neuroscience, Ankara, Turkey;
2 shared publications
Latest Publications
- Open Access
- 24 April 2026
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 20, 653-661
Selection of appropriate reference genes in Apoe-/- mouse brain
- 24 April 2026
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 20, 653-661
Open AccessSelection of appropriate reference genes in Apoe-/- mouse brain
- Open Access
- 16 December 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 12, 195552-195560
A Guided-Ensembling Approach for Cell Counting in Fluorescence Microscopy Images
Although deep learning and computer vision based approaches have demonstrated success in the field of cell counting and detection in microscopic images, they continue to have certain limitations. More specifically, they experience an overall increase in false positives when dealing with cell populations that show high density and heterogeneity. Existing approaches require the reselection of parameters for each new dataset to improve the accuracy of cell counting. Therefore, it is necessary to revise the fundamental models for each new microscopic image. This study introduces a novel neural network-based method that eliminates the need for retraining by combining the pretrained Cellpose and Stardist models. The accuracy of our proposed approach was evaluated on a variety of microscopic images. Despite variations in cell densities, our proposed approach demonstrated a notably improved cell counting performance in comparison to solely utilizing the Cellpose and Stardist models.
- 16 December 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 12, 195552-195560
Open AccessA Guided-Ensembling Approach for Cell Counting in Fluorescence Microscopy Images
Although deep learning and computer vision based approaches have demonstrated success in the field of cell counting and detection in microscopic images, they continue to have certain limitations. More specifically, they experience an overall increase in false positives when dealing with cell populations that show high density and heterogeneity. Existing approaches require the reselection of parameters for each new dataset to improve the accuracy of cell counting. Therefore, it is necessary to revise the fundamental models for each new microscopic image. This study introduces a novel neural network-based method that eliminates the need for retraining by combining the pretrained Cellpose and Stardist models. The accuracy of our proposed approach was evaluated on a variety of microscopic images. Despite variations in cell densities, our proposed approach demonstrated a notably improved cell counting performance in comparison to solely utilizing the Cellpose and Stardist models.
- Open Access
- 4 October 2023
- Published by S. Karger AG in Gerontology
- Vol. 69 (12) , 1424-1436
Long-Term Acetylcholinesterase Depletion Alters the Levels of Key Synaptic Proteins while Maintaining Neuronal Markers in the Aging Zebrafish (Danio rerio) Brain
Introduction: Interventions targeting cholinergic neurotransmission like acetylcholinesterase (AChE) inhibition distinguish potential mechanisms to delay age-related impairments and attenuate deficits related to neurodegenerative diseases. However, the chronic effects of these interventions are not well described. Methods: In the current study, global levels of cholinergic, cellular, synaptic, and inflammation-mediating proteins were assessed within the context of aging and chronic reduction of AChE activity. Long-term depletion of AChE activity was induced by using a mutant zebrafish line, and they were compared with the wildtype group at young and old ages. Results: Results demonstrated that AChE activity was lower in both young and old mutants, and this decrease coincided with a reduction in ACh content. Additionally, an overall age-related reduction in AChE activity and the AChE/ACh ratio was observed, and this decline was more prominent in wildtype groups. The levels of an immature neuronal marker were upregulated in mutants, while a glial marker showed an overall reduction. Mutants had preserved levels of inhibitory and presynaptic elements with aging, whereas glutamate receptor subunit levels declined. Conclusion: Long-term AChE activity depletion induces synaptic and cellular alterations. These data provide further insights into molecular targets and adaptive responses following the long-term reduction of AChE activity that was also targeted pharmacologically to treat neurodegenerative diseases in human subjects.
- 4 October 2023
- Published by S. Karger AG in Gerontology
- Vol. 69 (12) , 1424-1436
Open AccessLong-Term Acetylcholinesterase Depletion Alters the Levels of Key Synaptic Proteins while Maintaining Neuronal Markers in the Aging Zebrafish (Danio rerio) Brain
Introduction: Interventions targeting cholinergic neurotransmission like acetylcholinesterase (AChE) inhibition distinguish potential mechanisms to delay age-related impairments and attenuate deficits related to neurodegenerative diseases. However, the chronic effects of these interventions are not well described. Methods: In the current study, global levels of cholinergic, cellular, synaptic, and inflammation-mediating proteins were assessed within the context of aging and chronic reduction of AChE activity. Long-term depletion of AChE activity was induced by using a mutant zebrafish line, and they were compared with the wildtype group at young and old ages. Results: Results demonstrated that AChE activity was lower in both young and old mutants, and this decrease coincided with a reduction in ACh content. Additionally, an overall age-related reduction in AChE activity and the AChE/ACh ratio was observed, and this decline was more prominent in wildtype groups. The levels of an immature neuronal marker were upregulated in mutants, while a glial marker showed an overall reduction. Mutants had preserved levels of inhibitory and presynaptic elements with aging, whereas glutamate receptor subunit levels declined. Conclusion: Long-term AChE activity depletion induces synaptic and cellular alterations. These data provide further insights into molecular targets and adaptive responses following the long-term reduction of AChE activity that was also targeted pharmacologically to treat neurodegenerative diseases in human subjects.
- 1 March 2021
- Published by Elsevier in Ageing Research Reviews
- Vol. 66, 101228
Effects of caloric restriction on the antagonistic and integrative hallmarks of aging
- 1 March 2021
- Published by Elsevier in Ageing Research Reviews
- Vol. 66, 101228
Effects of caloric restriction on the antagonistic and integrative hallmarks of aging
- 15 December 2020
- Published by SAGE Publications in Rejuvenation Research
- Vol. 23 (6) , 485-497
Dietary and Pharmacological Interventions That Inhibit Mammalian Target of Rapamycin Activity Alter the Brain Expression Levels of Neurogenic and Glial Markers in an Age-and Treatment-Dependent Manner
Intermittent fasting (IF) and its mimetic, rapamycin extend lifespan and healthspan through mechanisms that are not fully understood. We investigated different short-term durations of IF and rapamycin on cellular and molecular changes in the brains of young (6–10 months) and old (26–31 months) zebrafish. Interestingly, our results showed that IF significantly lowered glucose levels while increasing DCAMKL1 in both young and old animals. This proliferative effect of IF was supported by the upregulation of foxm1 transcript in old animals. Rapamycin did not change glucose levels in young and old animals but had differential effects depending on age. In young zebrafish, proliferating cell nuclear antigen and the LC3-II/LC3-I ratio was decreased, whereas glial fibrillary acidic protein and gephyrin were decreased in old animals. The changes in proliferative markers and a marker of autophagic flux suggest an age-dependent interplay between autophagy and cell proliferation. Additionally, changes in glia and inhibitory tone suggest a suppressive effect on neuroinflammation but may push the brain toward a more excitable state. Mammalian target of rapamycin (mTOR) activity in the brain following the IF and rapamycin treatment was differentially regulated by age. Interestingly, rapamycin inhibited mTOR more potently in young animals than IF. Principal component analysis supported our conclusion that the regulatory effects of IF and rapamycin were age-specific, since we observed different patterns in the expression levels and clustering of young and old animals. Taken together, our results suggest that even a short-term duration of IF and rapamycin have significant effects in the brain at young and old ages, and that these are age and treatment dependent.
- 15 December 2020
- Published by SAGE Publications in Rejuvenation Research
- Vol. 23 (6) , 485-497
Dietary and Pharmacological Interventions That Inhibit Mammalian Target of Rapamycin Activity Alter the Brain Expression Levels of Neurogenic and Glial Markers in an Age-and Treatment-Dependent Manner
Intermittent fasting (IF) and its mimetic, rapamycin extend lifespan and healthspan through mechanisms that are not fully understood. We investigated different short-term durations of IF and rapamycin on cellular and molecular changes in the brains of young (6–10 months) and old (26–31 months) zebrafish. Interestingly, our results showed that IF significantly lowered glucose levels while increasing DCAMKL1 in both young and old animals. This proliferative effect of IF was supported by the upregulation of foxm1 transcript in old animals. Rapamycin did not change glucose levels in young and old animals but had differential effects depending on age. In young zebrafish, proliferating cell nuclear antigen and the LC3-II/LC3-I ratio was decreased, whereas glial fibrillary acidic protein and gephyrin were decreased in old animals. The changes in proliferative markers and a marker of autophagic flux suggest an age-dependent interplay between autophagy and cell proliferation. Additionally, changes in glia and inhibitory tone suggest a suppressive effect on neuroinflammation but may push the brain toward a more excitable state. Mammalian target of rapamycin (mTOR) activity in the brain following the IF and rapamycin treatment was differentially regulated by age. Interestingly, rapamycin inhibited mTOR more potently in young animals than IF. Principal component analysis supported our conclusion that the regulatory effects of IF and rapamycin were age-specific, since we observed different patterns in the expression levels and clustering of young and old animals. Taken together, our results suggest that even a short-term duration of IF and rapamycin have significant effects in the brain at young and old ages, and that these are age and treatment dependent.
- 1 October 2020
- Published by Elsevier in Neurobiology of Aging
- Vol. 94, 164-175
Zebrafish brain RNA sequencing reveals that cell adhesion molecules are critical in brain aging
- 1 October 2020
- Published by Elsevier in Neurobiology of Aging
- Vol. 94, 164-175
Zebrafish brain RNA sequencing reveals that cell adhesion molecules are critical in brain aging
- 1 June 2020
- Published by Elsevier in Neuroscience
- Vol. 436, 46-73
Expression Levels of SMAD Specific E3 Ubiquitin Protein Ligase 2 (Smurf2) and its Interacting Partners Show Region-specific Alterations During Brain Aging
- 1 June 2020
- Published by Elsevier in Neuroscience
- Vol. 436, 46-73
Expression Levels of SMAD Specific E3 Ubiquitin Protein Ligase 2 (Smurf2) and its Interacting Partners Show Region-specific Alterations During Brain Aging